Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes

Diabetologia

Volumn 53, Issue 10, 2010, Pages 2220-2223

  Bodvarsdottir T B ^a   Hove, K D ^b   Gotfredsen, C F ^a   Pridal, L ^a   Vaag, A ^b   Karlsen, A E ^c   Petersen, J S ^a  

^a NOVO NORDISK A S   (Denmark)

^b STENO DIABETES CENTER   (Denmark)

^c HAGEDORN RESEARCH INSTITUTE   (Denmark)

Author keywords

Animal model; Beta cell mass; Gastrin; Glycaemic control; Proton pump inhibitor; Type 2 diabetes

Indexed keywords

GASTRIN; GLUCOSE; INSULIN; LANSOPRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; FEMALE; GASTRIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; LOW DRUG DOSE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PSAMMOMYS OBESUS;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANALYSIS OF VARIANCE; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; GASTRINS; GERBILLINAE; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN-SECRETING CELLS; MALE; PROTON PUMPS;

EID: 77958033377     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1825-6     Document Type: Article

References (6)

1. Suarez-Pinzon WL, Lakey JRT, Brand SJ, Rabinovitch A (2005) Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet β-cells from pancreatic duct cells and an increase in functional β-cell mass. J Clin Endocrinol Metab 90:3401-3409
2. Rooman I, Lardon J, Bouwens L (2002) Gastrin stimulates β-cell neogenesis and increases islet mass from transdifferentiated but not from normal exocrine pancreas tissue. Diabetes 51:686-690
3. Suarez-Pinzon WL, Cembrowski GS, Rabinovitch A (2009) Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor restores normoglycaemia in non-obese diabetic mice. Diabetologia 52:1680-1682
4. Kaiser K, Yuli M, Üçkaya G et al (2005) Dynamic changes in β-cell mass and pancreatic insulin during the evolution of nutrition-dependent diabetes in Psammomys obesus: impact of glycemic control. Diabetes 54:138-145
5. Vedtofte L, Bödvarsdóttir TB, Gotfredsen CF, Karlsen AE, Knudsen LB, Heller RS (2010) Liraglutide, but not vildagliptin, restores normoglycaemia and insulin content in the animal model of type 2 diabetes, Psammomys obesus. Regul Pept 160:106-114
6. Gundersen HJG (2002) The smooth fractionator. J Microsc 207:191-210